Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry

By sjmartinez • July 22, 2023

Luo Y, Gordon J, Xu J, Kolstad KD, Chung L, Steen VD, Bernstein EJ; PHAROS Investigators. Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry. Rheumatology (Oxford). 2023 Jul 21:kead368. doi: 10.1093/rheumatology/kead368. Epub ahead of print. PMID: 37478347.

Tags: Pericardial Effusion, Prospective Cohort, Publications, pulmonary hypertension, Rheumatology, systemic sclerosis

ATS Core Curriculum 2026 Adult Pulmonary Medicine: Pulmonary Hypertension Diagnosis and Management

Cho JL, Camac E, Bernardo RJ, Carmona H, Del Valle KT, Forbes LM, Kolaitis NA, Mathai SK, Maximous SI, Melamed KH, Peck TJ, Soffler M,[...]

Polycyclic aromatic hydrocarbons, gut microbiome composition, impulsivity, and attention covary in a human cohort

Hammer AJ, Kasschau KD, Davis Ii EW, Hoffman P, Johnson-Camacho K, Alexiev A, Anderson K, Shannon J, Marriott LK, Sharpton TJ. Polycyclic aromatic hydrocarbons, gut[...]

Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study

Cromer SJ, Tesfaye H, Cho H, Wexler DJ, Ortega-Montiel J, Schmedt N, Shay CM, Paik JM, Patorno E. Effects of Empagliflozin on Cardiovascular Outcomes Are[...]